PL419082A1 - Xanthohumol for use in the treatment or prevention and prophylaxis of hemorrhoidal diseases and a composition containing xanthohumol - Google Patents
Xanthohumol for use in the treatment or prevention and prophylaxis of hemorrhoidal diseases and a composition containing xanthohumolInfo
- Publication number
- PL419082A1 PL419082A1 PL419082A PL41908216A PL419082A1 PL 419082 A1 PL419082 A1 PL 419082A1 PL 419082 A PL419082 A PL 419082A PL 41908216 A PL41908216 A PL 41908216A PL 419082 A1 PL419082 A1 PL 419082A1
- Authority
- PL
- Poland
- Prior art keywords
- xanthohumol
- prophylaxis
- prevention
- treatment
- composition containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/121—Ketones acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Przedmiotem niniejszego zgłoszenia jest ksantohumol lub jego farmaceutycznie dopuszczalna sól lub kompleks z metalem do zastosowania w leczeniu lub zapobieganiu i profilaktyce chorób hemoroidalnych. Zgłoszenie dotyczy także kompozycji farmaceutycznej do zastosowania w leczeniu lub zapobieganiu i profilaktyce chorób hemoroidalnych, zawierającej ksantohumol lub jego farmaceutycznie dopuszczalną sól lub kompleks z metalem jako składnik aktywny oraz co najmniej jedną farmaceutycznie dopuszczalną zaróbkę, rozczynnik albo nośnik.The subject of the present application is xanthohumol or a pharmaceutically acceptable salt or metal complex thereof for use in the treatment or prevention and prophylaxis of hemorrhoidal diseases. The application also relates to a pharmaceutical composition for use in the treatment or prevention and prophylaxis of hemorrhoidal diseases, comprising xanthohumol or a pharmaceutically acceptable metal salt or complex thereof as an active ingredient and at least one pharmaceutically acceptable excipient, excipient or carrier.
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL419082A PL235226B1 (en) | 2016-10-12 | 2016-10-12 | Xanthohumol for use in treatment or preventing haemorrhoidal diseases and the xanthohumol-containing composition |
| EP17804652.0A EP3525777A1 (en) | 2016-10-12 | 2017-10-12 | Xanthohumol for use in treating haemorrhoidal disease |
| PCT/IB2017/056302 WO2018069855A1 (en) | 2016-10-12 | 2017-10-12 | Xanthohumol for use in treating haemorrhoidal disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL419082A PL235226B1 (en) | 2016-10-12 | 2016-10-12 | Xanthohumol for use in treatment or preventing haemorrhoidal diseases and the xanthohumol-containing composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL419082A1 true PL419082A1 (en) | 2017-08-28 |
| PL235226B1 PL235226B1 (en) | 2020-06-15 |
Family
ID=59684565
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL419082A PL235226B1 (en) | 2016-10-12 | 2016-10-12 | Xanthohumol for use in treatment or preventing haemorrhoidal diseases and the xanthohumol-containing composition |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP3525777A1 (en) |
| PL (1) | PL235226B1 (en) |
| WO (1) | WO2018069855A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL429672A1 (en) * | 2019-04-17 | 2020-10-19 | Bioxan Spółka Z Ograniczoną Odpowiedzialnością | Preparation containing xanthohumol and use of xanthohumol |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103751717B (en) * | 2014-01-13 | 2015-11-18 | 李绍华 | A kind of pharmaceutical composition for the treatment of hemorrhoid |
| CN103845615B (en) * | 2014-03-24 | 2016-03-30 | 李周全 | One treats colpitic pharmaceutical composition |
-
2016
- 2016-10-12 PL PL419082A patent/PL235226B1/en unknown
-
2017
- 2017-10-12 EP EP17804652.0A patent/EP3525777A1/en not_active Withdrawn
- 2017-10-12 WO PCT/IB2017/056302 patent/WO2018069855A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2018069855A1 (en) | 2018-04-19 |
| PL235226B1 (en) | 2020-06-15 |
| EP3525777A1 (en) | 2019-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2024010140A (en) | NEW METHODS. | |
| PH12018502747A1 (en) | Boronic acid derivatives and therapeutic uses thereof | |
| MX393855B (en) | COMBINATION THERAPY INCLUDING A RAF INHIBITOR AND TRAMETINIB | |
| ZA201606320B (en) | Human plasma kallikrein inhibitors | |
| MX2022013612A (en) | Combinations of lsd1 inhibitors for the treatment of hematological malignancies. | |
| JOP20170135A1 (en) | Diazaspiroalkylmethyl-indoles | |
| EA201892395A1 (en) | DRUG COMPOSITIONS OF LSD1 INHIBITOR | |
| NZ733174A (en) | Quinazoline derivatives used to treat hiv | |
| MX368504B (en) | Amide derivatives and pharmaceutically acceptable salts thereof, preparation method therefor and medicinal application thereof. | |
| PH12016502355A1 (en) | Pharmaceutical composition | |
| PH12019502150A1 (en) | Compounds and methods for the treatment of parasitic diseases | |
| ZA201607489B (en) | Combination comprising a glucocorticoid and edo-s101 | |
| MX2021010297A (en) | Human plasma kallikrein inhibitors. | |
| MA39765A (en) | Pharmaceutical formulations of a pan-raf kinase inhibitor, processes for their preparation, and methods of use | |
| TW201613578A (en) | Pharmaceutical combinations | |
| JOP20190086A1 (en) | Naphthyridinone derivatives and their use in the treatment of arrhythmia | |
| NZ726132A (en) | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine | |
| MX2019010218A (en) | Pyrazole derivatives as bromodomain inhibitors. | |
| EA201792265A1 (en) | METHODS OF TREATING CARDIOVASCULAR DISEASES | |
| UA116499C2 (en) | (R) -PIRLINDOL AND ITS PHARMACEUTICALLY ACCEPTED SALTS FOR MEDICINAL USE | |
| PL419082A1 (en) | Xanthohumol for use in the treatment or prevention and prophylaxis of hemorrhoidal diseases and a composition containing xanthohumol | |
| EA201992149A1 (en) | COMBINATION OF ACTIVE INGREDIENTS CONTAINING ITS COMPOSITIONS AND THEIR APPLICATION IN TREATMENT OF SARCOPENIA | |
| PL429672A1 (en) | Preparation containing xanthohumol and use of xanthohumol | |
| NZ780408A (en) | Human plasma kallikrein inhibitors | |
| PL410369A1 (en) | New peptide derivatives, method for obtaining them, pharmaceutical composition, disinfecting composition and their application and a set |